Find Academic Supervisors

Patrice TankamView profile

Associate Professor

• Corneal Imaging
• Biomedical Optics
• Optical Metrology
• +5 more

Dr. Patrice Tankam is an Associate Professor at the Indiana University School of Optometry, specializing in biomedical optics and corneal imaging. He holds a Ph.D. in Optical Sciences from Université du Maine, France, and has conducted postdoctoral research at Institut d’Optique Rhone-Alpes and the University of Rochester's Institute of Optics. His work focuses on developing advanced optical techniques like optical coherence tomography (OCT) and microscopy for corneal disease diagnosis and ophthalmic applications. Educations: Bachelor in Mathematics & Physics (2004) - University of Yaoundé I, Cameroon M.S. in Optical Engineering (2007) - Université du Maine, France Ph.D. in Optical Sciences (2010) - Université du Maine, France Research Interests: Corneal imaging, optical metrology, interferometry, light-tissue interaction, OCT advancements, and fluorescence microscopy. His work bridges optical engineering with clinical ophthalmology to improve diagnostic tools for corneal diseases and ocular surface analysis. Articles & Contributions: His recent work explores polarization effects in OCT (2024), non-invasive corneal imaging (2023), and high-speed multimodal microscopy systems (2022). These studies advance cellular-resolution imaging for corneal disease pathways and clinical applications. Awards & Memberships: Active member of The Optical Society (OSA) and Association for Research in Vision and Ophthalmology (ARVO). Serves as a reviewer for journals like Optics Letters and Biomedical Optics Express. Labs & Teams: Leads the Tankam Lab at Indiana University, focusing on optical instrumentation and corneal disease imaging. Collaborates on projects involving MEMS-based probes and Gabor-domain OCT systems.

• Inflammation
• Thrombosis (arterial and venous)
• Resolution of inflammation
• +9 more

Professor Felicity Gavins is a Professor of Pharmacology and Royal Society Wolfson Fellow at Brunel University London, leading the Centre for Inflammation Research and Translational Medicine (CIRTM). She holds a BSc from the University of Sunderland and a PhD from Queen Mary University London, supported by the British Heart Foundation. Her research focuses on understanding immune cell interactions in vascular inflammation and thrombosis, particularly targeting the Annexin A1-Formyl Peptide Receptor pathway for novel therapies in cardiovascular and cerebrovascular diseases. She has secured major grants from the Royal Society, NIH, BHF, and AHA. Research Interests Her work spans inflammation resolution, thrombosis, sickle cell disease, and pre-clinical imaging. Key areas include neutrophil-platelet cross-talk, cerebrovascular dysfunction, and drug delivery systems. She employs advanced imaging techniques (confocal microscopy, MRI, PET) and multi-omics approaches to study vascular pathophysiology. Grants & Collaborations Funded projects include the Royal Society Wolfson Fellowship (2019-2025), NIH grants on cerebral microvasculature dysfunction, and collaborations with institutions like Harvard Medical School and Imperial College London. Her lab hosts international networks in immunopharmacology and translational medicine. Teaching & Mentoring She teaches advanced topics in pharmacology and mentors PhD students and early-career researchers. Current projects include resolving thromboinflammation in stroke and sickle cell disease, and developing non-mammalian models for thrombosis research.

Markus MuttenthalerView profile

Associate Professor

• Neuropeptide research
• Venom peptide drug discovery
• Molecular probe development
• +7 more

Associate Professor Markus Muttenthaler is a Group Leader at the Institute for Molecular Bioscience, University of Queensland. His research focuses on neuropeptide biology, venom-derived therapeutics, and translational drug discovery. He leads a team exploring oxytocin/vasopressin signaling in cancer, pain, and gastrointestinal disorders. Key projects include developing gut-stable peptides, anti-biofilm agents, and molecular probes for neuropharmacology. Education: PhD in Chemistry (not explicitly stated but implied by career trajectory). Research interests span chemical synthesis, GPCR targeting, and bioactive peptides from natural sources. He advises six PhD students and has pioneered methods in peptide drug discovery, earning the Miklós Bodanszky Award for contributions to peptide-based therapeutics. Collaborations involve global institutions in chemistry, biology, and clinical research. His lab develops cutting-edge tools like photoactivatable probes and kappa-opioid receptor ligands. Ongoing projects include oxytocin receptor imaging tracers for cancer and novel strategies to combat mucosal biofilms in IBS/UC.

• Molecular Simulations
• Computational Chemistry
• Materials Design
• +3 more

Dr. Meenakshi Joshi is a researcher at the Max Planck Institute for Dynamics of Complex Technical Systems , leading the Molecular Simulations and Design group in Magdeburg, Germany. Her research focuses on theoretical and computational studies of transition metal complexes for electrocatalytic hydrogen evolution, molecular catalyst design, and advanced materials characterization. She holds a Ph.D. and has extensively contributed to the development of novel catalysts for energy storage and green hydrogen technologies. Her work integrates computational chemistry (DFT, molecular dynamics) with experimental techniques to explore catalytic mechanisms and material behaviors. Current projects include designing rigidified FeFe hydrogenase mimics and studying ligand effects on catalytic activity. Her address is Sandtorstrasse 1, 39106 Magdeburg, Germany and can be reached at mjoshi@dynamicsofcomplexsystems.mpg.de . Research interests span inorganic chemistry, catalysis, and computational modeling of energy-related systems. Recent studies highlight her group's work on manganese/ruthenium complexes and bridging dithiolate ligands for hydrogen production applications.

Noel LazoView profile

Professor

• Protein Aggregation
• Neurodegenerative Diseases
• Diabetes Research
• +5 more

Noel Lazo serves as a Professor in the Carlson School of Chemistry and Biochemistry at Clark University, where he has maintained an active research laboratory since 2006. His work bridges chemistry, biochemistry, and neuroscience through investigations of protein aggregation disorders. Affiliated with both the Chemistry and Biology departments, he directs a multidisciplinary team examining molecular mechanisms underlying neurodegenerative and metabolic diseases. Dr. Lazo's educational background includes a B.S. from the University of the Philippines, M.S. from SUNY Syracuse, and Ph.D. in Chemistry (specializing in solid-state NMR) from Texas A&M University under James Haw. His postdoctoral training spanned biological NMR at Brigham and Women's Hospital and UCLA Neurology before his faculty appointment at Clark. His research focuses on proteolytic degradation and aggregation of proteins implicated in Alzheimer's disease and type 2 diabetes, particularly amyloid-β, ApoE isoforms, insulin-degrading enzyme, and islet amyloid polypeptide. Using integrated approaches including NMR spectroscopy, circular dichroism, mass spectrometry, and biochemical assays, his lab deciphers molecular mechanisms of protein oligomerization and degradation. Current projects investigate how anionic membranes modulate insulin degradation, differential ApoE isoform susceptibilities, and polyphenol effects on amyloid formation. Analysis of his 15 most recent publications (2010-2025) reveals an evolving research trajectory from fundamental peptide self-assembly mechanisms toward disease-relevant pathological processes. Early work characterized helix-to-sheet transitions and thioflavin T binding, while recent studies address Alzheimer's-diabetes connections through insulin-degrading enzyme modulation, ApoE proteolysis, and neurotoxic Aβ amplification cascades. Key thematic areas include membrane-protein interactions, enzyme kinetics regulation, and natural compound interventions. National Institute on Aging/NIH Grant R15AG055043 (2018-2021): 'Determinants of the Proteolytic Degradation of Soluble Amyloid-beta' Lise Ann and Leo E. Beavers II Endowment (recurring support for Alzheimer's/diabetes research) Dr. Lazo has mentored over 50 graduate and undergraduate students since 2006, with current trainees including PhD candidate Merc M. Kemeh and undergraduates Brianna Leckie, Joseph Tramontozzi, and Nathaniel Collins. His laboratory maintains active collaborations across neuroscience and biochemistry fields, with recent work featured in ACS Chemical Neuroscience and presented at Neuroscience 2022. The lab operates from S-335 Sackler Sciences Center, utilizing advanced spectroscopic and biochemical facilities for investigating protein complexes associated with late-onset disorders.

Barna DudokView profile

Assistant Professor

• Neuroscience
• Epilepsy Research
• Neurophysiology
• +3 more

Barna Dudok, Ph.D., is an Assistant Professor in the Department of Neurology at Baylor College of Medicine. His research focuses on understanding how GABAergic inhibitory interneurons shape circuit dynamics in healthy and epileptic brains, aiming to identify targets for neuromodulatory interventions. He holds a PhD from Semmelweis University (Budapest, Hungary) and completed postdoctoral training at Stanford University (Stanford, CA). Key research interests include endocannabinoid signaling, synaptic inhibition mechanisms, and circuit dynamics in epilepsy. His lab, the Laboratory of Neural Circuit Modulation , develops advanced imaging techniques and tools for analyzing neural activity, including super-resolution microscopy (STORM) and chemogenetic approaches. Collaborations with teams like Ivan Soltesz's lab at Stanford have yielded insights into hippocampal circuits and seizure control. Recent work highlights contributions to Science and Neuron , focusing on retrograde endocannabinoid signaling, ripple-selective GABAergic cells, and supramammillary regulation of locomotion. He shares lab resources via GitHub repositories (e.g., LNCM-lib), emphasizing open-source tools for data analysis and imaging. His team’s work integrates experimental neuroscience with computational modeling, advancing understanding of synaptic plasticity and therapeutic strategies for neurological disorders.

• Platelet Biology
• Hemostasis
• Thrombosis
• +3 more

Dr Simon Calaminus is a Senior Lecturer at the University of Hull, affiliated with the Faculty of Health Sciences and Hull York Medical School. He holds roles as Programme Director for the MSc in Pharmacology and Drug Development and teaches Phase 1 MBBS and Biomedical Science Pharmacology. Education: BSc in Biochemistry and PhD in Platelet Biology from the University of Birmingham (2004–2007), supervised by Prof Steve Watson. Postdoctoral research at the Beatson Institute (2007–2012) under Prof Laura Machesky, focusing on platelet biology and cancer cell signaling. Research Interests Investigates platelet responses to agonists/inhibitors and external pollutants like microplastics. Techniques include platelet spreading, in vitro thrombus formation, FACS analysis, and Western blotting. Recent work explores hypoxia effects on platelet function and quantum dot biocompatibility. Grants & Projects British Heart Foundation: £110k (2023–2025) studying hypoxia's role in prostacyclin-mediated platelet inhibition. Rosetrees Trust: £9k (2024) addressing microplastics as healthcare threats. Co-investigator on MRC/Wolfson imaging equipment grants (2024–2029). Lab & Collaborations Part of the Centre for Biomedicine, focusing on thrombosis, platelet signaling, and nanotechnology applications. Collaborates with industry and NHS experts for translational research.

Wesley LegantView profile

Assistant Professor

• Biomedical Imaging
• Biomedical Microdevices
• Cell Migration
• +5 more

Wesley Legant is an Assistant Professor in the Department of Pharmacology at the University of North Carolina-Chapel Hill School of Medicine. His research focuses on developing advanced imaging tools and microfabricated platforms to study cellular and tissue-level mechanics, particularly in 3D environments. Key areas include super-resolution microscopy, cell migration mechanisms, and engineered microtissues for studying mechanobiology. Legant holds appointments in both Pharmacology and the joint Biomedical Engineering department with NC State. Education: PhD in Bioengineering (University of Pennsylvania, 2012) and BS in Biomedical Engineering (Washington University in St. Louis, 2005). Awards include the NIH Director’s New Innovator Award (2019), Packard Fellowship, and Beckman Young Investigator recognition. Research interests span three core areas: 1) novel microscopy techniques like adaptive optics and lattice light-sheet imaging for live-cell observation, 2) mechanistic studies of cell migration in complex matrices using traction force microscopy, and 3) microfabricated platforms to investigate tissue-matrix interactions. His lab collaborates across disciplines to address fundamental biology questions with engineering innovations. Awards: Packard Fellow (2019), NIH Innovator Award (2019), Beckman Investigator (2019), Searle Scholar (2019) Labs: Jointly affiliated with Pharmacology and Biomedical Engineering departments; develops custom imaging instrumentation Grants: NIH funding supporting multi-scale microscopy and mechanobiology projects

Jan Freark de BoerView profile

Researcher

• Bile Acid Metabolism
• Cholesterol Transport
• Mouse Models of Disease
• +5 more

Jan Freark de Boer is an active researcher specializing in bile acid metabolism and cholesterol transport mechanisms, with significant contributions to understanding metabolic diseases using genetically modified mouse models. His work frequently involves CRISPR/Cas9 technology for creating humanized bile acid compositions in experimental models. His primary research interests include: Bile acid composition and its impact on metabolic health Cholesterol transport mechanisms and atherosclerosis development Interactions between gut microbiome and host metabolism Genetic models of metabolic disorders Dr. de Boer's publication record demonstrates consistent output in high-impact journals covering molecular mechanisms of bile acid signaling, with particular emphasis on CYP2C70 knockout models. His research shows strong interdisciplinary connections between molecular biology, cardiology, and gastroenterology. Notable scientific activities include frequent invited presentations at major conferences including the European Liver Meeting (EASL) and Dutch Liver Retreat, where he has presented findings on humanized bile acid pools and their metabolic effects. He has supervised multiple research projects and maintains active collaborations with Prof. Folkert Kuipers and other researchers in the Netherlands. His work contributes to UN Sustainable Development Goals related to good health and well-being through advancing understanding of metabolic diseases.

Muzhou WangView profile

Associate Professor

• Polymer Science
• Nanostructured Materials
• Self-Assembly Processes
• +3 more

Professor Muzhou Wang is an Associate Professor in the Department of Chemical and Biological Engineering at Northwestern University. His research focuses on polymer self-assembly, dynamics, and advanced optical microscopy techniques. The Wang Lab investigates nanoscale structures in polymers and biomaterials using cutting-edge microscopy, such as super-resolution imaging, to study real-time material behavior. Education: Ph.D. Chemical Engineering from MIT (201X), B.S. Chemical Engineering from Caltech (201X). Research emphasizes developing novel polymeric materials, particularly biomaterials and biohybrid systems. Key projects include understanding polymer clustering in solutions, interpenetrating polymer networks, and mechanical deformation at the single-chain level. The lab has pioneered high-throughput mechanical testing and correlative microscopy methods. Notable achievements include NSF CAREER Award, Camille Dreyfus Teacher-Scholar, and Sloan Fellowship. Over 30 peer-reviewed publications highlight contributions to polymer science, microscopy, and materials engineering. Advising includes mentoring 15+ students and postdocs. Current projects explore hybrid elastomers, mechano-responsive materials, and protein-polymer conjugates. Collaborations span academia and industry, including Dow, MIT, and Lawrence Berkeley National Lab. Labs/Teams: Wang Group at Northwestern, affiliated with the Materials Research Center and the International Institute for Nanotechnology. Active in organizing conferences and serving on editorial boards for Macromolecules and ACS Nano .

Kajally JobeView profile

Academic

• Industrial Chemistry
• Product Development
• Chemical Sensors
• +3 more

Dr Kajally Jobe is a Visiting Lecturer in Industrial Chemistry at the University of Surrey's School of Chemistry and Chemical Engineering, part of the Faculty of Engineering and Physical Sciences. He is also the Head of R&D and Chemical Regulatory Affairs at Aspen Pumps Group. With a PhD from Queen Mary University of London (2013) and prior roles as an Innovate UK Research Associate (2014–2017), he bridges academic research and industrial innovation. Education: BSc (Honours in Medicinal Chemistry, Wolverhampton, First Class), MSc (Synthetic Chemistry with Industrial Collaborations, University of Warwick), PhD (Chemistry, QMUL). Research focuses on STEM-marketing interfaces, product development, and chemical sensors. His commercial innovations include CondenCide®, VerteX®, and HydroFoam® 2.0. He led a £220K Innovate UK-funded KTP project (2017), achieving 'Outstanding' status for enhancing UK/EU chemical product distribution networks. Awards: Innovate UK’s Outstanding KTP Award (2017), Thieme SynFact 0725 of the Month (2011). Grants/Projects: Spearheaded a 3-year KTP collaboration with Advanced Engineering Ltd, resulting in advanced product commercialization strategies. Actively mentors graduates and promotes STEM education through pedagogic initiatives. Professional Affiliations: Chartered Chemist (CChem), Chartered Scientist (CSci), Royal Society of Chemistry (MRSC), STEM Ambassador. Holds certifications in Lean 6-Sigma, Agile Project Management, and Professional Marketing.

Sofia PascuView profile

Professor

• Bioinorganic Chemistry
• Materials Chemistry
• Nanomedicine
• +4 more

Sofia Pascu is a Professor of Bioinorganic and Materials Chemistry at the University of Bath, leading the S.I.P Research Group. She has held a Royal Society University Research Fellowship (2005-2015) and an ERC Consolidator Grant (2014-2020). Her research focuses on developing experimental techniques for functional materials in biosensing, molecular imaging, drug delivery, and sustainable chemistry. Key projects include the 'O2SENSE' initiative for oxygen sensing in living cells and collaborations on nanoceramics for tumor imaging. She has supervised 16 doctoral students and holds affiliations with the Centre for Sustainable Chemical Technologies and the Institute of Sustainability and Climate Change. Education: MSc in Chemistry (Babes-Bolyai University, Romania), PhD in Main Group Organometallic Chemistry (Cluj-Napoca, 2001), DPhil in Transition Metal Catalysis (University of Oxford, 2004). Previous roles include Research Associate positions at Oxford (2002-2003) and Cambridge (2003-2005). Research interests span sustainable chemistry (CO₂ conversion, catalysis), metals in medicine, and multimodal imaging (optical/PET). Her lab employs advanced techniques like synchrotron X-ray diffraction, NMR, and multiphoton fluorescence imaging. Funding sources include ERC, EPSRC, BBSRC, and industry partners like GSK and Nikon Bioimaging. Awards: ERC Consolidator Grant (€1.88M), Royal Society URF Grants: EPSRC IAA, STFC CDN+, EU Horizon 2020 Labs/Teams: S.I.P Research Group, collaborations across Chemistry and Biomedical Engineering

Rifka VlijmView profile

Assistant Professor

• Cell Biology
• Biophysics
• Super-Resolution Microscopy
• +5 more

Rifka Vlijm is an Assistant Professor at the University of Groningen's Faculty of Science and Engineering, within the Molecular Biophysics department. She specializes in super-resolution microscopy, particularly STED, to study cellular protein structures and cell division mechanisms. Her research emphasizes developing live-cell imaging techniques, including high-throughput protocols, machine-learning integration, and non-toxic imaging methods. Education and Career: PhD at TU Delft with Prof. Cees Dekker (single-molecule chromatin studies), Postdoc at NIH (centromere DNA stability), and STED microscopy expertise under Nobel laureate Stefan Hell. Joined Groningen in 2019 as a tenure-track faculty member. Research Interests: Focus on ESCRT-III polymer dynamics, centrosome linkers, peroxisomal proteins, and microscopy innovations. Key contributions include STED-based cell division visualization in archaea and live-cell yeast protocols. Awards and Grants: 2022 NWO-M1 Grant, FSE Research Grant, NWO-XL Grant (consortium). Nominated for Aspasia Prize (2023). Active in national advisory roles, including NWO committees and the Dutch Biophysics organization. Grants and Networks: Member of APNet (national network for assistant professors), advisory boards for NWO work councils, and conference leadership roles. Her lab's innovations span microscopy automation and interdisciplinary collaborations.

• Pediatric Neurology
• Telemedicine
• Neuroimmunology
• +5 more

Vijay Vishwanath is a Clinical Associate Professor of Neurology and Pediatrics at the University of Southern California (USC), specializing in pediatric neurology and clinician education. His work focuses on clinical case studies, telemedicine applications in child neurology, and rare disease diagnostics. He holds a primary affiliation with USC’s medical school and is reachable at vvishwan@usc.edu . Research interests include pediatric neurological disorders, metabolic diseases, immunodeficiency syndromes, and epilepsy management. Notable contributions examine rare conditions like neonatal hemidystonia and Hemophagocytic Lymphohistiocytosis, emphasizing diagnostic challenges. He also explores telemedicine ethics post-pandemic and drug dosing strategies for pediatric epilepsy. Publications span decades, reflecting expertise in clinical neurology, biochemical disorders, and interdisciplinary topics like consumer market localization. His work integrates clinical practice with academic rigor, advocating for evidence-based pediatric care.

Peter NilssonView profile

Professor

• Organic Chemistry
• Neurodegenerative Diseases
• Biomedical Research
• +3 more

Peter Nilsson is a Professor of Organic Chemistry at Linköping University, affiliated with the Department of Physics, Chemistry and Biology (IFM). His research focuses on developing tracer molecules to study protein aggregates in neurodegenerative diseases like Alzheimer’s. He emphasizes interdisciplinary collaboration, working with researchers in chemistry, physics, and medicine. His work includes creating fluorescent molecules that bind to specific proteins, enabling precise diagnostics and potential therapies. Notably, his lab’s molecules have shown promise in reducing amyloid plaque in mouse models of Alzheimer’s. Peter actively engages in education, contributing to the Master’s Programme in Chemistry through applied chemistry courses. He values hands-on experimentation and team-based science, maintaining long-term collaborations with institutions worldwide. Key Collaborations: Indiana University, MRC Laboratory of Molecular Biology (Cambridge), University Hospital Zurich. Research Themes: Protein aggregation mechanisms, diagnostic tools, and drug development for neurodegenerative diseases. Interdisciplinary Approach: Blends organic chemistry with medical and physical sciences to address complex biological problems. Peter’s innovations in tracer molecules have advanced understanding of diseases such as Alzheimer’s and Parkinson’s, with potential applications in early diagnosis and treatment. His lab’s work bridges fundamental research and clinical translation, aiming to improve patient outcomes through molecular precision.